These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 8401621

  • 21. Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer.
    Sabichi AL, Lerner SP, Atkinson EN, Grossman HB, Caraway NP, Dinney CP, Penson DF, Matin S, Kamat A, Pisters LL, Lin DW, Katz RL, Brenner DE, Hemstreet GP, Wargo M, Bleyer A, Sanders WH, Clifford JL, Parnes HL, Lippman SM.
    Clin Cancer Res; 2008 Jan 01; 14(1):224-9. PubMed ID: 18172274
    [Abstract] [Full Text] [Related]

  • 22. Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.
    Fernandez-Gomez J, Solsona E, Unda M, Martinez-Piñeiro L, Gonzalez M, Hernandez R, Madero R, Ojea A, Pertusa C, Rodriguez-Molina J, Camacho JE, Isorna S, Rabadan M, Astobieta A, Montesinos M, Muntañola P, Gimeno A, Blas M, Martinez-Piñeiro JA, Club Urológico Español de Tratamiento Oncológico (CUETO).
    Eur Urol; 2008 May 01; 53(5):992-1001. PubMed ID: 17950987
    [Abstract] [Full Text] [Related]

  • 23. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, Witjes JA, van der Heijden AG, Naspro R, Colombo R.
    Urology; 2004 Mar 01; 63(3):466-71. PubMed ID: 15028439
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Superficial urinary bladder cancer. Results from the Finnbladder studies and a review on instillation treatments.
    Jauhiainen K, Rintala E.
    Ann Chir Gynaecol Suppl; 1993 Mar 01; 206():31-8. PubMed ID: 8291866
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP, Witjes JA, Oosterhof GO, Debruyne MJ.
    Semin Urol Oncol; 1996 Feb 01; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [Abstract] [Full Text] [Related]

  • 30. Low dose Pasteur bacillus Calmette-Guerin regimen in stage T1, grade 3 bladder cancer therapy.
    Hurle R, Losa A, Ranieri A, Graziotti P, Lembo A.
    J Urol; 1996 Nov 01; 156(5):1602-5. PubMed ID: 8863547
    [Abstract] [Full Text] [Related]

  • 31. [Results of BCG in the treatment of pTa and pT1 bladder tumors. Evaluation of a long protocol using 75 mg of Pasteur strain BCG].
    Ayed M, Ben Hassine L, Ben Slama R, Chelbi N, Ghozzi S, Drissi H, Jemni M, Chebil M.
    Prog Urol; 1998 Apr 01; 8(2):206-10. PubMed ID: 9615929
    [Abstract] [Full Text] [Related]

  • 32. Reassessment of conservative management for stage T1N0M0 transitional cell carcinoma of the bladder.
    Zhang GK, Uke ET, Sharer WC, Borkon WD, Bernstein SM.
    J Urol; 1996 Jun 01; 155(6):1907-9. PubMed ID: 8618284
    [Abstract] [Full Text] [Related]

  • 33. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E, Iborra I, Rubio J, Casanova J, Almenar S.
    BJU Int; 2004 Dec 01; 94(9):1258-62. PubMed ID: 15610101
    [Abstract] [Full Text] [Related]

  • 34. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y, Oogo Y, Takase K, Hamano A, Yamashita Y, Noguchi S, Satomi Y.
    Hinyokika Kiyo; 2004 Nov 01; 50(11):767-71. PubMed ID: 15628536
    [Abstract] [Full Text] [Related]

  • 35. Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma.
    Friedrich MG, Pichlmeier U, Schwaibold H, Conrad S, Huland H.
    Eur Urol; 2007 Oct 01; 52(4):1123-29. PubMed ID: 17383080
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study.
    Denzinger S, Wieland WF, Otto W, Filbeck T, Knuechel R, Burger M.
    BJU Int; 2008 Mar 01; 101(5):566-9. PubMed ID: 17986289
    [Abstract] [Full Text] [Related]

  • 39. [Prophylaxis of superficial bladder cancer with 1 mg of intravesical BCG: comparison with other doses].
    Corti Ortíz D, Rivera Garay P, Avilés Jasse J, Hidalgo Carmona F, MacMillan Soto G, Coz Cañas LF, Vargas Delaunoy R, Susaeta Saénz de San Pedro R.
    Actas Urol Esp; 1993 Apr 01; 17(4):239-42. PubMed ID: 8342413
    [Abstract] [Full Text] [Related]

  • 40. [Management of Ta, T1, and in situ bladder carcinoma: what is new?].
    Irani J.
    Prog Urol; 2008 May 01; 18 Suppl 5():S94-8. PubMed ID: 18585634
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.